GelStat Corporation (Other OTC:GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products has terminated the Letter of Intent (LOI) to acquire Beveragette Ventures, LLC.    

Make sure you are first to receive timely information on GelStat Corporation when it hits the newswire. Sign up for GelStat's email news alert system today at: http://ir.stockpr.com/gelstat/request-information

ABOUT GELSTAT CORPORATION

GelStat Corporation is dedicated to providing safe and effective over-the-counter (OTC) treatments. GelStat's first two products GelStat Migraine and GelStat Sleep are sold through direct-to-consumer channels as well as in a limited number of independent retailers and pharmacies. The Company also has a suite of additional healthcare products in various stages of development that address large consumer markets. For more information, visit www.gelstat.com.

CONTACT: Gerald Kieft
         CEO
         GelStat Corporation
         772-283-0020
GelStat (PK) (USOTC:GSAC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse GelStat (PK)
GelStat (PK) (USOTC:GSAC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse GelStat (PK)